Valiant Organics Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹304 Cr +93.6% YoYSee revenue, profit and what management said. You are viewing Q2 FY26.
VO

Valiant Organics Ltd

Q2 FY26Chemicals & Petrochemicals

Valiant Organics Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹157Cr
−1.9% YoY
−23% QoQ
Net profit
₹6Cr
Turned profitable YoY
−25% QoQ
Margin
13%
+12.5 pp YoY
+1 pp QoQ

Based on Valiant Organics Ltd's Q2 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹411
Market cap₹1.2K Cr
P/E23.7

The short version

Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12). Q2-FY26 Consolidated Financial Highlights: - EBITDA: INR 212 Mn (up from INR 24 Mn in Q2-FY25) - Operating EBITDA Margin: 13.48% (up from 1.50% in Q2-FY25) - PAT: INR 57 Mn (compared to a loss of INR 125 Mn in Q2-FY25) - PAT Margin: 3.62% (compared to -7.80% in Q2-FY25) - Year-on-year change shows a significant turnaround in profitability and margin expansion.

From Valiant Organics Ltd's Q2 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12).
  • Q2-FY26 standalone revenue from operations: INR 1,572 million, down 1.9% year-on-year (Page 14).
  • Q2-FY26 sales volumes by chemistry (MT):
  • Chlorination: 274 MT (Page 11)
  • Hydrogenation: 394 MT
  • Ammonolysis: 286 MT

2 more points from Valiant Organics Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

See what Valiant Organics Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.

Valiant Organics Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Valiant Organics Ltd Q2 FY26 results — key figures

Valiant Organics Ltd Q2 FY26 reported results vs Q2 FY25, ₹ crore
₹ CrQ2 FY26Q2 FY25YoYQ1 FY26QoQ
Revenue157160-1.9%204-23%
Operating profit (EBITDA)211+2000%25-16%
Operating margin13%0.5%+12.5 pp12%+1 pp
Profit before tax7-14—11-36.4%
Net profit (PAT)6-12—8-25%
EPS (₹)2.02-4.63—2.93-31.1%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Gujarat Alkalies (Q2 FY26)

    2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against

  • Dynemic Products (Q2 FY26)

    Quarterly revenue for Q2 FY 25-26: ₹8,935 lakhs (Page 12, 10, 5) . Key investor presentation takeaways from Dynemic Products's Q2 FY26 investor presentation — a

  • Platinum Industr (Q2 FY26)

    Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri

  • IVP (Q2 FY26)

    Revenue from Operations for Q2FY26: ₹146.95 crores . Key investor presentation takeaways from IVP's Q2 FY26 investor presentation — and how it ranks against sec

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Valiant Organics Ltd Q2 FY26 results?

Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12). Q2-FY26 Consolidated Financial Highlights: - EBITDA: INR 212 Mn (up from INR 24 Mn in Q2-FY25) - Operating EBITDA Margin: 13.48% (up from 1.50% in Q2-FY25) - PAT: INR 57 Mn (compared to a loss of INR 125 Mn in Q2-FY25) - PAT Margin: 3.62% (compared to -7.80% in Q2-FY25) - Year-on-year change shows a significant turnaround in profitability and margin expansion.

What is Valiant Organics Ltd share price analysis?

Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.